307 related articles for article (PubMed ID: 34015930)
1. Epigallocatechin Gallate Inhibits the Uridylate-Specific Endoribonuclease Nsp15 and Efficiently Neutralizes the SARS-CoV-2 Strain.
Hong S; Seo SH; Woo SJ; Kwon Y; Song M; Ha NC
J Agric Food Chem; 2021 Jun; 69(21):5948-5954. PubMed ID: 34015930
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic potential of green tea catechin, (-)-epigallocatechin-3-
Dinda B; Dinda S; Dinda M
Phytomed Plus; 2023 Feb; 3(1):100402. PubMed ID: 36597465
[TBL] [Abstract][Full Text] [Related]
3. Biochemical Characterization of Emerging SARS-CoV-2 Nsp15 Endoribonuclease Variants.
Wilson IM; Frazier MN; Li JL; Randall TA; Stanley RE
J Mol Biol; 2022 Oct; 434(20):167796. PubMed ID: 35995266
[TBL] [Abstract][Full Text] [Related]
4. Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of nsp15 endoribonuclease.
Canal B; Fujisawa R; McClure AW; Deegan TD; Wu M; Ulferts R; Weissmann F; Drury LS; Bertolin AP; Zeng J; Beale R; Howell M; Labib K; Diffley JFX
Biochem J; 2021 Jul; 478(13):2465-2479. PubMed ID: 34198324
[TBL] [Abstract][Full Text] [Related]
5. Identification of potential target endoribonuclease NSP15 inhibitors of SARS-COV-2 from natural products through high-throughput virtual screening and molecular dynamics simulation.
Hu LC; Ding CH; Li HY; Li ZZ; Chen Y; Li LP; Li WZ; Liu WS
J Food Biochem; 2022 May; 46(5):e14085. PubMed ID: 35128681
[TBL] [Abstract][Full Text] [Related]
6. Pharmacoinformatics approach based identification of potential Nsp15 endoribonuclease modulators for SARS-CoV-2 inhibition.
Savale RU; Bhowmick S; Osman SM; Alasmary FA; Almutairi TM; Abdullah DS; Patil PC; Islam MA
Arch Biochem Biophys; 2021 Mar; 700():108771. PubMed ID: 33485847
[TBL] [Abstract][Full Text] [Related]
7. Prediction of potential inhibitors against SARS-CoV-2 endoribonuclease: RNA immunity sensing.
Al-Rashedi NAM; Munahi MG; Ah ALObaidi L
J Biomol Struct Dyn; 2022 Jul; 40(11):4879-4892. PubMed ID: 33357040
[TBL] [Abstract][Full Text] [Related]
8.
Sharma A; Goyal S; Yadav AK; Kumar P; Gupta L
J Biomol Struct Dyn; 2022 Jan; 40(1):86-100. PubMed ID: 32896226
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of anti-viral stress granule formation by coronavirus endoribonuclease nsp15 ensures efficient virus replication.
Gao B; Gong X; Fang S; Weng W; Wang H; Chu H; Sun Y; Meng C; Tan L; Song C; Qiu X; Liu W; Forlenza M; Ding C; Liao Y
PLoS Pathog; 2021 Feb; 17(2):e1008690. PubMed ID: 33635931
[TBL] [Abstract][Full Text] [Related]
10. Identification of phytochemicals as potential therapeutic agents that binds to Nsp15 protein target of coronavirus (SARS-CoV-2) that are capable of inhibiting virus replication.
Kumar S; Kashyap P; Chowdhury S; Kumar S; Panwar A; Kumar A
Phytomedicine; 2021 May; 85():153317. PubMed ID: 32943302
[TBL] [Abstract][Full Text] [Related]
11. Epigallocatechin-3-gallate, an active ingredient of Traditional Chinese Medicines, inhibits the 3CLpro activity of SARS-CoV-2.
Du A; Zheng R; Disoma C; Li S; Chen Z; Li S; Liu P; Zhou Y; Shen Y; Liu S; Zhang Y; Dong Z; Yang Q; Alsaadawe M; Razzaq A; Peng Y; Chen X; Hu L; Peng J; Zhang Q; Jiang T; Mo L; Li S; Xia Z
Int J Biol Macromol; 2021 Apr; 176():1-12. PubMed ID: 33548314
[TBL] [Abstract][Full Text] [Related]
12. The green tea catechin epigallocatechin gallate inhibits SARS-CoV-2 infection.
Henss L; Auste A; Schürmann C; Schmidt C; von Rhein C; Mühlebach MD; Schnierle BS
J Gen Virol; 2021 Apr; 102(4):. PubMed ID: 33830908
[TBL] [Abstract][Full Text] [Related]
13. Structural and Biochemical Characterization of Endoribonuclease Nsp15 Encoded by Middle East Respiratory Syndrome Coronavirus.
Zhang L; Li L; Yan L; Ming Z; Jia Z; Lou Z; Rao Z
J Virol; 2018 Nov; 92(22):. PubMed ID: 30135128
[TBL] [Abstract][Full Text] [Related]
14. SARS-CoV-2 nsp15 endoribonuclease antagonizes dsRNA-induced antiviral signaling.
Otter CJ; Bracci N; Parenti NA; Ye C; Asthana A; Blomqvist EK; Tan LH; Pfannenstiel JJ; Jackson N; Fehr AR; Silverman RH; Burke JM; Cohen NA; Martinez-Sobrido L; Weiss SR
Proc Natl Acad Sci U S A; 2024 Apr; 121(15):e2320194121. PubMed ID: 38568967
[TBL] [Abstract][Full Text] [Related]
15. Identification of promising antiviral drug candidates against non-structural protein 15 (NSP15) from SARS-CoV-2: an
Khan RJ; Jha RK; Singh E; Jain M; Amera GM; Singh RP; Muthukumaran J; Singh AK
J Biomol Struct Dyn; 2022 Jan; 40(1):438-448. PubMed ID: 32885740
[TBL] [Abstract][Full Text] [Related]
16. Vitamin D is a potential inhibitor of COVID-19: In silico molecular docking to the binding site of SARS-CoV-2 endoribonuclease Nsp15.
Shalayel MH; Al-Mazaideh GM; Aladaileh SH; Al-Swailmi FK; Al-Thiabat MG
Pak J Pharm Sci; 2020 Sep; 33(5):2179-2186. PubMed ID: 33824127
[TBL] [Abstract][Full Text] [Related]
17. High-throughput screening of the ReFRAME, Pandemic Box, and COVID Box drug repurposing libraries against SARS-CoV-2 nsp15 endoribonuclease to identify small-molecule inhibitors of viral activity.
Choi R; Zhou M; Shek R; Wilson JW; Tillery L; Craig JK; Salukhe IA; Hickson SE; Kumar N; James RM; Buchko GW; Wu R; Huff S; Nguyen TT; Hurst BL; Cherry S; Barrett LK; Hyde JL; Van Voorhis WC
PLoS One; 2021; 16(4):e0250019. PubMed ID: 33886614
[TBL] [Abstract][Full Text] [Related]
18. Inactivating Three Interferon Antagonists Attenuates Pathogenesis of an Enteric Coronavirus.
Deng X; Buckley AC; Pillatzki A; Lager KM; Faaberg KS; Baker SC
J Virol; 2020 Aug; 94(17):. PubMed ID: 32554697
[TBL] [Abstract][Full Text] [Related]
19. Reversible and irreversible inhibitors of coronavirus Nsp15 endoribonuclease.
Chen J; Farraj RA; Limonta D; Tabatabaei Dakhili SA; Kerek EM; Bhattacharya A; Reformat FM; Mabrouk OM; Brigant B; Pfeifer TA; McDermott MT; Ussher JR; Hobman TC; Glover JNM; Hubbard BP
J Biol Chem; 2023 Nov; 299(11):105341. PubMed ID: 37832873
[TBL] [Abstract][Full Text] [Related]
20. Tipiracil binds to uridine site and inhibits Nsp15 endoribonuclease NendoU from SARS-CoV-2.
Kim Y; Wower J; Maltseva N; Chang C; Jedrzejczak R; Wilamowski M; Kang S; Nicolaescu V; Randall G; Michalska K; Joachimiak A
Commun Biol; 2021 Feb; 4(1):193. PubMed ID: 33564093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]